Background: Adverse Event Following Immunization (AEFI) is any unfavorable event occurring following vaccination related to the vaccine administration and or its handling. AEFI can lead to death or a life-threatening condition requiring hospitalization with or without permanent sequel. Hence, this study was conducted to determine the knowledge of AEFI among mothers of children aged 0–23 months, its prevalence and actions of mothers of following AEFIs. Methodology: This was a cross-sectional study conducted among 400 mothers of children aged 0–23 months between November 2017 and April 2018 using quantitative method of data collection. IBM SPSS version 20 was used for data analysis where chi square was used as a test of association a P -value of ≤ 0.05 considered statistically significant. Results: The mean age of the respondents in the study was 29.0 ±5.3 years with 222 (55.5%) demonstrating good knowledge of AEFI. The prevalence of AEFI was found to be 46.5% with fever as the most experienced AEFI accounting for 90.3% of all cases experienced followed by pain and swelling mentioned by 141 (75.8%) and 26 (14.0%) respectively. Only 26 (14.5) of the mothers were adjudged to have taken appropriate action following the experience of AEFI in their children. Appropriateness of actions taken by the mothers following the occurrence of AEFI was influenced by the mother’s employment status (COR= 3.84; 95% CI=1.366–10.575; P =0.007). Conclusion: This study has demonstrated a sub-optimal level of knowledge of AEFI among the mothers of children aged 0–23 months with a relatively high self-reported prevalence and poor level of appropriateness of actions taken following AEFI.

The study aimed to assess the strengths and weaknesses, opportunities and threats influencing the achievement of prevention of mother-to-child transmission of hepatitis B virus. It also sought to suggest recommendations to improve the current prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria. A critical appraisal of the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria was conducted. The WHO health system framework was used to assess the prevention of mother-to-child transmission of hepatitis B virus system. Considering the recent call by the World Health Organization to eliminate hepatitis and the existence of a robust prevention of mother-to-child transmission of human immunodeficiency virus health system, the prevention of mother-to-child transmission of hepatitis B virus health system in Nigeria is riddled with numerous challenges. These range from a health worker crisis, poor leadership and governance, inadequate health information, medicines, vaccines and technologies and poor service delivery. Urgent action in the Nigerian prevention of mother-to-child transmission of hepatitis B virus health system is required if Nigeria is to achieve its goal of eliminating hepatitis by 2021.

The prevalence of male condom use is low in Plateau State. The predictors of condom use are level of wealth, being unmarried, and primary level of education. Having only a primary level of education and been in the middle class reduces the likelihood of using condoms while being unmarried increases it.

Background: Since the first reported case of Lassa fever (LF) in Jos, Plateau state Nigeria in the early 70's, the state has been plagued with increasing number of cases. This could be due to poor environmental practices, food and personal hygiene. By the end of August 2017 there were 42 reported cases with 15 confirmed cases. Sadly, over the years there have been challenges with reporting and investigation of cases. This could be due to weak health systems commonly seen in developing countries. Methods and Materials:We reviewed 2012-2016 surveillance data from the State Ministry of Health (SMoH) using Microsoft Excel. Descriptive analysis was conducted on the reported LF cases in the state. Results: Between the years 2012 -2016 there were 109 reported LF cases, with 57 (52.3%) males and 52 (47.7%) females. The mean age of the reported cases was 27.9± 13.6 years. Out of these, 23 (21.1%) were confirmed cases: 1 (4.5%) in 2012, none in 2013, 2014 and 2015, and 21 (91.3%) in 2016.The male: female ratio was10 (43.5%): 13 (56.5%). Six (26.1%) of the confirmed cases were health workers. The case fatality rate of the confirmed cases was 52.2%. Even though there is significant association between LF and death (P-value = 0.003) the odds ratio, 0.215 (95% CI) is low. The reporting years show consistent increasing trend from 2012 to 2016, except for 2015 where there was a decline in the number of reported cases. In 2016 there were 74 (67.9%) cases, 5 (4.6%) in 2015, 15 (13.7%) in 2014, 12 (11.0%) in 2013 and 3 (2.6%) in 2012. Conclusion: Even though reported cases are increasing, there are still gaps observed in the surveillance system of the SMoH. The annual recurrence of LF outbreak in the state without reciprocal preventive efforts on ground to combating it has exposed the populace and health workers to ill-health and death.

Background: The first reported Yellow fever outbreak in Nigeria occurred in 1931.The latest outbreak in Nigeria, commenced in September 2017. It is active in seven states and suspected cases have been reported in sixteen states, inclusive of Plateau state. The last reported outbreak in Plateau state occurred in Jos in 1969 with an estimated 100,000 cases.Materials and Methods: The cases and health workers involved in management were interviewed. Hospital records, laboratory and surveillance data were reviewed.Results: Case 1: A 6-year-old girl from Tudun-Wada, Jos Plateau state presented with fever (38.6oC), abdominal pain, sore throat and jaundice. Liver function test (AST: 398U/L, ALT: 96U/L). Treatment included ribavirin, ceftriaxone, anti-oxidants, intravenous fluids, blood transfusion. ELISA-IgM was positive for YF, but negative on PNRT.Case 2: A 10-year-old boy from the same family with case 1 presented with fever (39.0oC), abdominal pain, diarrhoea and jaundice.  Liver function test (AST: 315 U/L, ALT: 126U/L). Treatment is same as case 1 plus metronidazole. ELISA-IgM was positive for YF, but negative on PNRT, while PCR was positive for Lassa fever.Twenty-three contacts (17 healthcare workers, 6 family members) were traced and daily monitoring instituted.Conclusion: The potential for a major urban outbreak of Yellow Fever in Plateau state and Nigeria is already present. Advocacy, health education and enforcement of vector control measures need to be intensified by the State Ministry of Health. Surveillance for rapid case finding and proactive vaccination also need to be intensified to forestall a disaster.